New York State Common Retirement Fund’s Neuronetics STIM Stock Holding History

New York State Common Retirement Fund’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,800	Closed	-$8.41K	–	3320
2026 Q1	$8.41K	Hold	5,800	–	–	﹤0.01%	3095
2025 Q4	$8K	Hold	5,800	–	–	﹤0.01%	3154
2025 Q3	$15.8K	Sell	5,800 -23,700	-80%	-$84.2K	﹤0.01%	3129
2025 Q2	$103K	Buy	+29,500	New	+$116K	﹤0.01%	2605
2022 Q3	–	Sell	-262	Closed	-$1K	–	3436
2022 Q2	$1K	Sell	262 -6,600	-96%	-$19.2K	﹤0.01%	3407
2022 Q1	$21K	Hold	6,862	–	–	﹤0.01%	3285
2021 Q4	$31K	Hold	6,862	–	–	﹤0.01%	3277
2021 Q3	$45K	Sell	6,862 -14,538	-68%	-$139K	﹤0.01%	3258
2021 Q2	$343K	Buy	+21,400	New	+$296K	﹤0.01%	2790
2020 Q2	–	Sell	-12,800	Closed	-$24K	–	3277
2020 Q1	$24K	Hold	12,800	–	–	﹤0.01%	3088
2019 Q4	$57K	Hold	12,800	–	–	﹤0.01%	3106
2019 Q3	$106K	Hold	12,800	–	–	﹤0.01%	3014
2019 Q2	$160K	Buy	12,800 +6,500	+103%	+$91.9K	﹤0.01%	2931
2019 Q1	$96K	Hold	6,300	–	–	﹤0.01%	2962
2018 Q4	$122K	Buy	+6,300	New	+$138K	﹤0.01%	2906

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

New York State Common Retirement Fund's STIM Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 5,800 shares — an estimated $8.41K sold.

New York State Common Retirement Fund first reported a position in STIM in Q4 2018 and held it in 15 quarters. The position peaked at $343K in Q2 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

New York State Common Retirement Fund reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
New York State Common Retirement Fund sold 5,800 Neuronetics shares in Q2 2026, an estimated $8.41K.
New York State Common Retirement Fund first reported a position in Neuronetics in Q4 2018 and held it in 15 quarters.
New York State Common Retirement Fund's Neuronetics position peaked at $343K in Q2 2021.
86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.